Novotrop is identified with somatropin, recombinant human growth hormone produced using biotechnology. Somatropin is structurally comparable to naturally occurring human growth hormone and acts through growth hormone receptors to influence growth and metabolism.
Prescription somatropin has recognized uses involving specific growth hormone deficiencies and certain growth-related disorders. Its clinical application depends on diagnosis, age, growth status, and other medical factors.
Growth hormone treatment can affect glucose metabolism, fluid balance, musculoskeletal tissues, and insulin sensitivity. Appropriate monitoring is therefore important, particularly when therapy is continued over an extended period.
Reviews
There are no reviews yet.